Alteration of ACTH and Cortisol Levels After Estradiol Valerate Treatment in a Male Subject With Gender Dysphoria: A Case Report
Authors:
Open Access
- 5 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 10, 751
Abstract
Background: The number of subjects with gender dysphoria has been increasing. In general, male-to-female transsexual subjects are treated with estradiol valerate therapy. In this report, we showed the time course of ACTH and cortisol levels after estradiol valerate injection in a male subject with gender dysphoria. It seemed that alteration of estradiol levels influenced ACTH and cortisol levels via some pathway. Case presentation: A 31-year-old man with estradiol valerate therapy for gender dysphoria was referred due to an elevation of serum cortisol levels. She started hormone therapy at 26 years old. Her laboratory analyses showed an elevation of plasma ACTH and cortisol levels. There were no remarkable changes in the adrenal gland and pituitary gland. Her estradiol levels were elevated 7 days after estradiol valerate injection, but they were not detected 18 days after such treatment. Interestingly, plasma ACTH and serum cortisol levels were moderately decreased 7 days after estradiol valerate injection, but both were markedly elevated 18 days after such treatment. Conclusions: We should bear in mind the possibility of elevation in plasma ACTH and serum cortisol levels when we start estradiol valerate injection in subjects with gender dysphoria. In addition, we may need to check ACTH and cortisol levels when we use estrogen replacement therapy for a long period of time in subjects with gender dysphoria.Keywords
This publication has 19 references indexed in Scilit:
- 11β-Hydroxysteroid Dehydrogenases: Intracellular Gate-Keepers of Tissue Glucocorticoid ActionPhysiological Reviews, 2013
- Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2009
- Reduced maternal corticosteroid‐binding globulin and cortisol levels in pre‐eclampsia and gamete recipient pregnanciesClinical Endocrinology, 2007
- Gender differences in hypothalamic–pituitary–adrenal (HPA) axis reactivityPsychoneuroendocrinology, 2006
- Increased urinary cortisol levels during the menopause transitionMenopause, 2006
- Effects on the Male Endocrine System of Long-term Treatment with Gonadotropin-releasing Hormone Agonists and Estrogens in Male-to-Female TranssexualsHormone and Metabolic Research, 2006
- Estrogen Regulates 11β-Hydroxysteroid Dehydrogenase-1 and -2 Localization in Placental Syncytiotrophoblast in the Second Half of Primate PregnancyEndocrinology, 2001
- Estrogen Supplementation Attenuates Glucocorticoid and Catecholamine Responses to Mental Stress in Perimenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 1999
- Effects of gender and age on the levels and circadian rhythmicity of plasma cortisolThe Journal of Clinical Endocrinology & Metabolism, 1996
- Regulation of 11β-hydroxysteroid dehydrogenase by sex steroids in vivo : further evidence for the existence of a second dehydrogenase in rat kidneyJournal of Endocrinology, 1993